Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Single-dose, Crossover, Two-period, Two-sequence, Laboratory-blinded, Comparative Bioavailability Study of Meloxicam 15 mg Tablets in Healthy Volunteers Under Fasting Condition.

NCT05125588 is registered in ClinicalTrials.gov with Joint Stock Company "Farmak" as lead sponsor.

NCT NCT05125588
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05125588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Single-dose, Crossover, Two-period, Two-sequence, Laboratory-blinded, Comparative Bioavailability Study of Meloxicam 15 mg Tablets in Healthy Volunteers Under Fasting Condition.
Lead sponsor
Joint Stock Company "Farmak"
Phase
Phase 1
Overall status
Completed
Start date
January 29, 2014
Completion date
February 26, 2014
Enrollment
24 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pharmacokinetics